Medical College of Wisconsin

Compiled by PlainTrial · August 8, 2026

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Medical College of Wisconsin sits in the top decile of US sponsors by registered trial count (#79 of 15,742 sponsors by registered trial count).

447 total trials 95 currently recruiting 236 completed early-phase tilt top decile by trial count

Medical College of Wisconsin: 447 sponsored US clinical trials, 95 recruiting.

Medical College of Wisconsin sponsors 447 registered US clinical trials on ClinicalTrials.gov, 95 of them currently recruiting, and 236 completed. 28 of these trials are in Phase 3-4 (later-stage) and 129 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Stroke, with 10 trials.

Medical College of Wisconsin ranks in the top decile of sponsors by registered trial count (#79 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

F 46/100

236 of 286 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (82.5%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

447 total, page 2 of 9

Medical College of Wisconsin

Top-decile sponsor footprint

Open and recent trials

MCW Alpha/Beta T-Cell and B-Cell Depletion With Targeted ATG Dosing

Venetoclax to Augment Epigenetic Modification and Chemotherapy

Pilot Study Lp299v Supplementation in Chronic Heart Failure

Stand Up for Your Health with a Sit-stand Desk

Mixed Methods Study of Health-Related Social Needs in African American Adults With Chronic Kidney Disease and Type 2 Diabetes Mellitus

Role of Autophagy in Type 2 Diabetes Microvascular Dysfunction

Investigation of Profile-related Evidence Determining Individualized Cancer Therapy for Patients With Aggressive Malignancies and Poor Prognoses

Every Day Counts: A Lifestyle Program for Women With Metastatic Breast Cancer

Striated Esophageal Motor Function Modulation in Health and Disease

High Dose Re-Irradiation Utilizing Advanced Deformable Image Registration (DIR) and Individualized Organ At Risk (OAR) Dose Calculations With Organ Specific Toxicity Analysis

Coherent Optical Detection of Middle Ear Disease

Understanding and Addressing Disparities in Cancer Therapy Induced Inflammation and Associated Endothelial Dysfunction

Isatuximab, Pomalidomide, Elotuzumab and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma

Optimizing Neurocognition With Whole Brain Radiation Therapy (WBRT) Using Upfront Pulsed Reduced Dose-Rate (PRDR) Technique

Protocol Number: HJKC3-0003. Treatment Free Remission After Asciminib Based Therapy in Chronic Phase Chronic Myeloid Leukemia (CP-CML) Patients Who Relapsed After a Prior Attempt at TKI Discontinuation

Bortezomib, Isatuximab, Cyclophosphamide and Dexamethasone Induction in Transplant-Eligible Multiple Myeloma Patients With Renal Insufficiency

Sickle Cell Improvement: Enhancing Care in the Emergency Department

MRI-Guided Adaptive Radiation Therapy for Organ Preservation in Rectal Cancer

Social Relationships and Accelerated Aging in Hematopoietic Cell Transplant Survivors

Gestational Diabetes and Pharmacotherapy (GAP)

Auricular Vagal Nerve Stimulation for Hypermobile Ehlers-Danlos Syndrome

PurIST Classification-Guided Adaptive Neoadjuvant Chemotherapy by RNA Expression Profiling of EUS Aspiration Samples

Blinatumomab After TCR Alpha Beta/CD19 Depleted HCT

Delayed Primary Closure Using Negative Pressure Wound Therapy

Botulinum Toxin A for the Treatment of Chemotherapy Induced Peripheral Neuropathy

CAR-20/19-T Cells in Patients With Relapsed Refractory B Cell Malignancies

Transcranial Alternating Current Stimulation (tACS) in Aphasia

Abemaciclib for Bone and Soft Tissue Sarcoma With Cyclin-Dependent Kinase (CDK) Pathway Alteration

Recognition of Circulating Tumor DNA in Soft Tissue Sarcoma

Ischemic Conditioning Improves Walking Function Post Stroke

Preoperative Fractionated Radiation Therapy Versus Stereotactic Body Radiation Therapy for Resectable or Borderline Resectable, or Locally Advanced Type A Pancreatic Adenocarcinoma

Diagnosis of Fatty Liver With Outpatient Ultrasound

Fetal Electrophysiologic Abnormalities in High-Risk Pregnancies Associated With Fetal Demise

Pancreatic Cancer Adaptive Neoadjuvant Chemotherapy Trial

Gastroschisis Outcomes of Delivery (GOOD) Study

Long-term Follow-up Study of Patients Receiving CAR-T Cells

NovoTTF Treatment Signatures in Glioblastoma Patients At Autopsy

External Pharyngeal Exerciser and Dysphagia

Intra- and Inter-fraction Changes in Radiation Therapy

External Pharyngeal Exerciser and Pharyngeal Phase of Swallowing

Mechanisms Preventing Pharyngeal Reflux

External UES Band (Shaker Pressure Band) and GERD

Genetic Variants and Susceptibility to Diseases of Prematurity in Very Low Birth-Weight Infants

PTGS1 Genetic Variation and Increased Risk for Persistent Pulmonary Hypertension of the Newborn

Genetics Of Autoimmunity In Type I Diabetes

Understanding the Implementation of Cued Exercise Using Wearable Devices and a Custom Smartphone Application Following Bone Marrow Transplant.

Left Atrial Pressure-Guided Heart Failure Optimization During Atrial Fibrillation Ablation (LAP AF-HF)

Multi-Institutional Transgender & Gender-Diverse Breast Cancer Study

Estrogen and Microvascular Function

HD-tDCS for Phonological Impairment in Aphasia

Phase Distribution

Therapeutic Areas

What is open in the Medical College of Wisconsin pipeline

Medical College of Wisconsin: open-pipeline peers nationwide

Sponsors near 447 trials (± recruiting share)

Sponsors near 21% open enrollment (± trial volume)

Related